Healthcare -
Biotechnology - NASDAQ - US
$ 5.4
9.09 %
$ 46.3 M
Market Cap
-0.39
P/E
KPTI - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities KPTI - Karyopharm Therapeutics Inc.
95.5 M
LAST VALUE
70.76%
2 YEAR CAGR
4.01%
5 YEAR CAGR
13.10%
10 YEAR CAGR